IP Library Granted Patent US 8,337,493
Granted Patent B2
US 8,337,493 · App. 13/013,413 · Granted Dec 25, 2012

Handheld transdermal drug delivery and analyte extraction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,337,493
App. No.
13/013,413
Granted
Dec 25, 2012
Kind
B2
Abstract

Apparatus ( 20 ) for application to skin of a subject is provided. The apparatus includes a board ( 30 ) having a first surface and a second surface, the first surface including a plurality of ablation electrodes ( 41 ), which are adapted to be applied to the skin, and the second surface including one or more contact pads ( 32 ), each one of the contact pads electrically coupled to at least one of the ablation electrodes. The apparatus further includes one or more driving electrodes ( 28 ). An energy applicator (e.g., motor 22 ), coupled to the driving electrodes, is adapted to pass the driving electrodes over the contact pads. A power source (e.g., power unit 102 ) is adapted to drive a current from the driving electrodes, to the contact pads, and to the ablation electrodes. The current is capable of ablating at least a portion of stratum corneum of the skin in a vicinity of the ablation electrodes, so as to facilitate transdermal transport of a substance.

Claims (18)

1. Apparatus for ablating stratum corneum, comprising:

a housing;

a set of two or more wires coupled to and supported by the housing so as not to touch each other, each wire having

two ends, each end defining an electrode; and

an intermediate portion coupled to a coupling element; and

wherein each of the wires is bent so that both electrodes of one wire together with the electrodes of at least the other wire substantially form a plane; and

wherein the electrodes are configured to function as electrodes for ablating stratum corneum of skin of a subject when applied to the skin.

2. Apparatus according to claim 1 , wherein each wire has a shape generally like a parabola.

3. Apparatus according to claim 1 , wherein each wire is adapted to be supported by the housing by passing through the housing, and wherein a portion of each wire that passes through the housing is shaped so as to define an angular bend within the housing.

4. The apparatus according to claim 1 , wherein each of the electrodes is configured to have a contact area with the skin characterized by a diameter of 10-150 microns.

5. The apparatus according to claim 4 , wherein each of the electrodes is configured to have a contact area with the skin characterized by a diameter of 60-100 microns.

6. The apparatus according to claim 1 , further comprising a control unit configured to ablate the stratum corneum by driving a current into the stratum corneum via the electrodes.

7. The apparatus according to claim 6 , wherein the control unit is configured to detect electrical impedance of the stratum corneum, and to terminate driving the current in response thereto.

8. The apparatus according to claim 6 , wherein the control unit is configured to ablate the stratum corneum by driving the current for a fixed length of time, determined in advance to be sufficient to achieve a desired degree of ablation of the stratum corneum.

9. The apparatus according to claim 6 , wherein the control unit is configured to ablate the stratum corneum by driving a current into the stratum corneum via the electrodes, the current having a frequency of between 10 kHz and 4000 kHz.

10. The apparatus according to claim 9 , wherein the control unit is configured to ablate the stratum corneum by driving a current into the stratum corneum via the electrodes, the current having a frequency of between 50 kHz and 500 kHz.

11. The apparatus according to claim 1 , wherein the number of the electrodes in each set is double the number of the wires in the set.

12. The apparatus according to claim 1 , wherein the intermediate portion and the coupling element are also electrically coupled.

Assignments (4)
RELEASE (REEL 043925 / FRAME 0001) Recorded Apr 4, 2022
From: ING CAPITAL LLC
To: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
Reel/Frame 059593/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2017
From: SOHN, ZE'EV
To: TRANSPHARMA MEDICAL LTD.
Reel/Frame 044146/0831 →
SECURITY AGREEMENT Recorded Sep 20, 2017
From: SYNERON MEDICAL LTD.; CANDELA CORPORATION; PRIMAEVA CORPORATION
To: ING CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 043925/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2012
From: TRANSPHARMA MEDICAL LTD
To: SYNERON MEDICAL LTD
Reel/Frame 028108/0010 →